Document text
Principal Investigator: Stefan Worgall
Organization: WEILL MEDICAL COLL OF CORNELL UNIV
Fiscal Year: 2024
Award: $799,479
Funding agency: National Institute of Allergy and Infectious Diseases
PROJECT SUMMARY
SARS-CoV-2 infections in children are mostly milder and less lethal than in adults. This lower
incidence of relevant disease associated with SARS-CoV-2 has surprisingly also been observed
for children with asthma, the most common chronic respiratory and inflammatory disease in
children. As social distancing and masks have dramatically but temporarily decreased the
spread of common viral respiratory infections, this created the positive effect of a significant
decrease of viral-triggered asthma in children. The growing prevalence of SARS-CoV-2 infection
in children and the resurgence of non-SARS-CoV-2 respiratory viral infections make it critical
and timely to understand how SARS-CoV-2 infection shapes respiratory outcomes and immune
responses to other respiratory viruses and the upcoming SARS-CoV-2 vaccines.
In addition to a strong genetic predisposition, asthma is strongly linked to viral respiratory
infections, and infectious stimuli can have long-term epigenetic consequences that shape
immune responses to subsequent infections. We propose that a common genetic variation that
alters sphingolipid levels in children with asthma may also result in limited pathogenesis of
SARS-CoV-2 in children with asthma. This proposal aims to test the hypothesis is that common
genetic variation in asthma moderate age-dependent outcomes and immune responses to
SARS-CoV-2 infection and vaccines utilizing an NYC pediatric asthma cohort that was started
early in the pandemic. This cohort is uniquely suited to the hypothesis as it (1) includes children
of all ages with and without asthma; (2) is enriched for children from ethnic, racial, and
socioeconomic backgrounds associated with health disparities and high exposure to SARS-
CoV-2; and (3) has already enrolled more than three hundred with a high antibody positivity rate
since May 2020. The availability of detailed questionnaire data on asthma and SARS-CoV-2
exposure, biospecimen that include blood (including stored PBMC), and nasal samples will
enable us to address these three Specific Aims, to (1) determine the age-dependent effect of
SARS-CoV-2 infection on subsequent respiratory health in asthmatic children; (2) define the
epigenetic and transcriptomic effect of SARS-CoV-2 infection on hematopoietic stem cells,
and (3) define the effects of common genetic asthma risk alleles on responses to SARS-CoV-2
infection of nasal epithelial cells and subsequent infection with respiratory syncytial virus and
rhinovirus. These studies will be supported by a team with expertise in viral immunology,
pediatric asthma, and epigenetics of immune responses and will inform on age- and disease-
specific impact and mechanisms of SARS-CoV-2 and common respiratory viruses in children.
Terms: <0-11 years old><17q21><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><2019-nCoV variant><2019-nCoV variant forms><2019-nCoV variant strains><21+ years old><ATAC sequencing><ATAC-seq><ATACseq><Address><Adult><Adult Human><Affect><Age><Airway health><Alleles><Allelomorphs><Antibodies><Assay for Transposase-Accessible Chromatin using sequencing><Asthma><Asthma in Children><B.1.1.529><Binding><Blood><Blood Precursor Cell><Blood Reticuloendothelial System><Bronchial Asthma><COVID crisis><COVID epidemic><COVID pandemic><COVID prevalence><COVID-19 crisis><COVID-19 disease prevalence><COVID-19 epidemic><COVID-19 era><COVID-19 exposure><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 infection><COVID-19 outbreak><COVID-19 pandemic><COVID-19 period><COVID-19 prevalence><COVID-19 public health crisis><COVID-19 vaccine><COVID-19 variant><COVID-19 variant forms><COVID-19 variant strains><COVID-19 virus><COVID-19 virus infection><COVID-19 years><COVID19 infection><COVID19 outbreak><COVID19 virus><Cell Body><Cells><Child><Child Youth><Childhood><Childhood Asthma><Children (0-21)><Chronic><Clinic><CoV-2><CoV2><Common Cold Virus><Data><Disease><Disorder><Drugs><Enrollment><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Epithelial Cells><Ethnic Origin><Ethnicity><Frequencies><Gene Expression><Genetic><Genetic Diversity><Genetic Polymorphism><Genetic Predisposition><Genetic Predisposition to Disease><Genetic Susceptibility><Genetic Variation><Genetic propensity><Hematopoietic Progenitor Cells><Hematopoietic stem cells><Immune><Immune response><Immunes><Immunological response><Immunology><Immunomodulation><Impairment><Incidence><Infection><Inflammasome><Inflammatory><Inflammatory Response><Inherited Predisposition><Inherited Susceptibility><Intermediary Metabolism><Link><Masks><Medication><Membrane><Metabolic Processes><Metabolism><Minor><Molecular Interaction><Monitor><Mucosa><Mucosal Tissue><Mucous Membrane><Nasal><Nasal Epithelium><Nasal Passages Nose><New York City><Nose><Nuclear><Omicron variant><Outcome><PBMC><Pathogenesis><Pediatric asthma><Peripheral Blood Mononuclear Cell><Pharmaceutical Preparations><Physical distancing><Questionnaires><Race><Races><Reaction><Reporting><Respiratory Epithelium><Respiratory System, Nose, Nasal Passages><Respiratory syncytial virus><Rhinovirus><Rhinovirus infection><Risk Factors><Risk-associated variant><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 B.1.1.529><SARS-CoV-2 epidemic><SARS-CoV-2 exposure><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infection><SARS-CoV-2 infection prevalence><SARS-CoV-2 omicron><SARS-CoV-2 omicron variant><SARS-CoV-2 outbreak><SARS-CoV-2 pandemic><SARS-CoV-2 pathogenesis><SARS-CoV-2 prevalence><SARS-CoV-2 vaccine><SARS-CoV-2 variant><SARS-CoV-2 variant forms><SARS-CoV-2 variant strains><SARS-CoV2><SARS-CoV2 exposure><SARS-CoV2 infection><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 exposure><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 outbreak><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Severities><Shapes><Social Distance><Sphingolipids><Stimulus><Structure of respiratory epithelium><T-Cells><T-Lymphocyte><Testing><VDAC1><VDAC1 gene><Vaccines><Variant><Variation><Viral><Viral Diseases><Viral Respiratory Tract Infection><Virus Diseases><Wheezing><Wuhan coronavirus><adulthood><after COVID-19 infection><after SARS-CoV-2 infection><after SARS-CoV2 infection><after infection by SARS-CoV-2><after severe acute respiratory distress syndrome CoV-2 infection><age associated><age correlated><age dependent><age group><age linked><age related><age specific><ages><airway epithelium><assay for transposase accessible chromatin followed by sequencing><assay for transposase accessible chromatin seq><assay for transposase accessible chromatin sequencing><assay for transposase-accessible chromatin with sequencing><asthma attack><asthma exacerbation><asthmatic><blood cell progenitor><blood progenitor><blood stem cell><blood-forming stem cell><chronic airway disease><chronic inflammatory disease><chronic respiratory disease><cohort><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 exposure><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 infection><coronavirus disease 2019 outbreak><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 vaccine><coronavirus disease 2019 variant><coronavirus disease 2019 variant forms><coronavirus disease 2019 variant strains><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 outbreak><coronavirus disease-19 pandemic><coronavirus disease-19 vaccine><coronavirus disease-19 virus><disparity in health><drug/agent><enroll><epigenetically><exacerbation in asthma><exacerbation prone asthma><exacerbation prone asthmatic><exposure to COVID-19><exposure to SARS-CoV-2><exposure to SARS-CoV2><exposure to Severe acute respiratory syndrome coronavirus 2><exposure to coronavirus disease 2019><following COVID-19 infection><following SARS-CoV-2 infection><following SARS-CoV2 infection><following infection by SARS-CoV-2><following severe acute respiratory distress syndrome CoV-2 infection><genetic etiology><genetic mechanism of disease><genetic vulnerability><genetically predisposed><hCoV19><health disparity><hematopoietic progenitor><hematopoietic stem progenitor cell><hemopoietic progenitor><hemopoietic stem cell><host response><immune modulation><immune regulation><immune system response><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><immunoresponse><infected with COVID-19><infected with COVID19><infected with Rhinovirus><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><kids><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><membrane structure><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><omicron variant of COVID-19><omicron variant of SARS-CoV-2><outbreak of SARS-CoV-2><pandemic><pandemic disease><pathogenic virus><pediatric><peripheral blood><polymorphism><pore forming protein><porin><post SARS-CoV-2 infection><previous COVID-19 infection><previous SARS-CoV-2 infection><previous SARS-CoV2 infection><previous severe acute respiratory distress syndrome CoV-2 infection><prior COVID-19 infection><prior SARS-CoV-2 infection><prior SARS-CoV2 infection><prior severe acute respiratory distress syndrome CoV-2 infection><progenitor><programs><protective effect><racial><racial background><racial origin><receptor expression><respiratory><respiratory health><respiratory infection virus><respiratory pathogen><respiratory tract epithelium><respiratory virus><response><risk allele><risk gene><risk genotype><risk loci><risk locus><risk variant><scRNA-seq><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe acute respiratory syndrome coronavirus 2 B.1.1.529><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 pathogenesis><severe acute respiratory syndrome coronavirus 2 variant><severe acute respiratory syndrome coronavirus 2 variant forms><severe acute respiratory syndrome coronavirus 2 variant strains><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><socio-economic><socio-economically><socioeconomically><socioeconomics><thymus derived lymphocyte><transcriptomics><uptake><vaccine against 2019-nCov><vaccine against COVID-19><vaccine against SARS-CoV-2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine candidates against SARS-CoV-2><vaccine for novel coronavirus><vaccines preventing COVID><vaccines to prevent COVID><viral infection><viral pathogen><viral respiratory infection><virus infection><virus pathogen><virus-induced disease><wheeze><youngster>